Max Robotics — Global Service Robot Directory + US Certification

About

Christopher Harle is a leading figure in the evolution of coronary revascularization, with a research focus on hybrid and robotic-assisted surgical techniques for treating multivessel coronary artery disease. His most impactful work, a 2019 comparative effectiveness study (55 citations), demonstrates that hybrid coronary revascularization (HCR)—which integrates coronary artery bypass grafting with percutaneous intervention—offers a compelling alternative to off-pump CABG, with long-term follow-up data supporting its viability. Harle has been instrumental in advancing the "ultrafast track" approach to robotic-assisted minimally invasive CABG, showing that these techniques can reduce sedation times and enable early extubation, thereby improving patient recovery. He has also critically examined the reasons and timing for conversion to sternotomy in robotic procedures, providing essential safety data that guides surgical decision-making. Through his work, Harle has helped define the future of coronary arterial revascularization, balancing the benefits of minimally invasive surgery with the proven durability of surgical grafting. His research continues to shape best practices in hybrid and robotic cardiac surgery, making him a key contributor to the field’s ongoing transformation.